Zinc supplementation improved the treatment of colitis in a mouse model of the disease by upregulating the expression of MT1 and MT2, regulating intestinal inflammation in terms of intestinal epithelial integrity, the immune system, metabolic function, and the defense against oxidative stress [82]. Here, MT2A is linked to colitis.